Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Pantaleo

Showing results (71-80 of 144) with videos related to

Pageof 15
Sort By:
Angiogenesis|November 30, 2016
An exploratory association of polymorphisms in angiogenesis-related genes with susceptibility, clinical response and toxicity in gastrointestinal stromal tumors receiving sunitinib after imatinib failureGloria Ravegnini, Margherita Nannini, Corrado Zenesini, et al.
Minerva Chirurgica|February 16, 2017
What is changing in the surgical treatment of gastrointestinal stromal tumors after multidisciplinary approach? A comprehensive literature's reviewBelinda DE Simone, Luca Ansaloni, Massimo Sartelli, et al.
Epigenetics|April 16, 2019
The rs17084733 variant in the <i>KIT</i> 3' UTR disrupts a miR-221/222 binding site in gastrointestinal stromal tumour: a sponge-like mechanism conferring disease susceptibilityGloria Ravegnini, César Serrano, Vittorio Simeon, et al.
Clinical Sarcoma Research|August 22, 2014
Dystrophin deregulation is associated with tumor progression in KIT/PDGFRA mutant gastrointestinal stromal tumorsMaria A Pantaleo, Annalisa Astolfi, Milena Urbini, et al.
Tumori|August 20, 2009
11C-acetate PET for early prediction of sunitinib response in metastatic renal cell carcinomaAlessandra Maleddu, Maria A Pantaleo, Paolo Castellucci, et al.
Clinical and Experimental Medicine|February 20, 2009
Advances in preclinical therapeutics development using small animal imaging and molecular analyses: the gastrointestinal stromal tumors modelM A Pantaleo, L Landuzzi, G Nicoletti, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|July 28, 2016
Polymorphisms in DNA repair genes in gastrointestinal stromal tumours: susceptibility and correlation with tumour characteristics and clinical outcomeGloria Ravegnini, Margherita Nannini, Vittorio Simeon, et al.
Molecular Imaging and Biology|April 10, 2010
Evaluation of modified PEG-anilinoquinazoline derivatives as potential agents for EGFR imaging in cancer by small animal PETMaria A Pantaleo, Eyal Mishani, Cristina Nanni, et al.
European Journal of Human Genetics : EJHG|September 18, 2014
Folate-related polymorphisms in gastrointestinal stromal tumours: susceptibility and correlation with tumour characteristics and clinical outcomeSabrina Angelini, Gloria Ravegnini, Margherita Nannini, et al.
Clinical Nuclear Medicine|November 9, 2011
When should F-18 FDG PET/CT be used instead of 68Ga-DOTA-peptides to investigate metastatic neuroendocrine tumors?Chiara Fuccio, Alessandra Musto, Silvia Cambioli, et al.
Pageof 15

Showing results (71-80 of 144) with videos related to

Sort By:
Pageof 15
Angiogenesis|November 30, 2016
An exploratory association of polymorphisms in angiogenesis-related genes with susceptibility, clinical response and toxicity in gastrointestinal stromal tumors receiving sunitinib after imatinib failureGloria Ravegnini, Margherita Nannini, Corrado Zenesini, et al.
Minerva Chirurgica|February 16, 2017
What is changing in the surgical treatment of gastrointestinal stromal tumors after multidisciplinary approach? A comprehensive literature's reviewBelinda DE Simone, Luca Ansaloni, Massimo Sartelli, et al.
Epigenetics|April 16, 2019
The rs17084733 variant in the <i>KIT</i> 3' UTR disrupts a miR-221/222 binding site in gastrointestinal stromal tumour: a sponge-like mechanism conferring disease susceptibilityGloria Ravegnini, César Serrano, Vittorio Simeon, et al.
Clinical Sarcoma Research|August 22, 2014
Dystrophin deregulation is associated with tumor progression in KIT/PDGFRA mutant gastrointestinal stromal tumorsMaria A Pantaleo, Annalisa Astolfi, Milena Urbini, et al.
Tumori|August 20, 2009
11C-acetate PET for early prediction of sunitinib response in metastatic renal cell carcinomaAlessandra Maleddu, Maria A Pantaleo, Paolo Castellucci, et al.
Clinical and Experimental Medicine|February 20, 2009
Advances in preclinical therapeutics development using small animal imaging and molecular analyses: the gastrointestinal stromal tumors modelM A Pantaleo, L Landuzzi, G Nicoletti, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|July 28, 2016
Polymorphisms in DNA repair genes in gastrointestinal stromal tumours: susceptibility and correlation with tumour characteristics and clinical outcomeGloria Ravegnini, Margherita Nannini, Vittorio Simeon, et al.
Molecular Imaging and Biology|April 10, 2010
Evaluation of modified PEG-anilinoquinazoline derivatives as potential agents for EGFR imaging in cancer by small animal PETMaria A Pantaleo, Eyal Mishani, Cristina Nanni, et al.
European Journal of Human Genetics : EJHG|September 18, 2014
Folate-related polymorphisms in gastrointestinal stromal tumours: susceptibility and correlation with tumour characteristics and clinical outcomeSabrina Angelini, Gloria Ravegnini, Margherita Nannini, et al.
Clinical Nuclear Medicine|November 9, 2011
When should F-18 FDG PET/CT be used instead of 68Ga-DOTA-peptides to investigate metastatic neuroendocrine tumors?Chiara Fuccio, Alessandra Musto, Silvia Cambioli, et al.
Pageof 15